James M. Musser
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
James M. Musser has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
E A Graviss
5 shared publicationsL D Teeter
4 shared publicationsG J Adams
2 shared publicationsGerald J. Adams
Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas
2 shared publicationsH M El Sahly
Department of Pathology, Baylor College of Medicine, Houston, Texas 77030, USA
2 shared publicationsH Soini
2 shared publications
Latest Publications
- 1 March 2004
- Vol. 8 (3) , 333-40
Recurrent tuberculosis in Houston, Texas: a population-based study.
To determine the predictors of recurrence of tuberculosis (TB), the drug resistance pattern of Mycobacterium tuberculosis strains recovered from recurrent TB patients, and the frequency of re-infection with a new M. tuberculosis strain among patients with recurrent disease. A population-based, retrospective case-control study using the Houston Tuberculosis Initiative database. We found that, among 100 patients with recurrent TB who completed adequate therapy for a first episode of TB, not receiving directly observed therapy, pulmonary disease, HIV/AIDS diagnosis, not having a family physician, being unemployed and using public transportation were predictors of recurrent disease. There was a significant increase in drug-resistant M. tuberculosis strains in the second episode of disease compared to the first episode (21.3% vs. 8.2%, P = 0.04). Exogenous re-infection with a new strain of M. tuberculosis was found to cause 24-31% of recurrent TB. Recurrent TB in Houston is associated with a significant increase in drug-resistant M. tuberculosis strains. Re-infection with a new M. tuberculosis strain causes a significant proportion of recurrent TB in an area of low TB incidence. Patients with HIV/AIDS constitute a population at increased risk of disease recurrence.
- 1 March 2004
- Vol. 8 (3) , 333-40
Recurrent tuberculosis in Houston, Texas: a population-based study.
To determine the predictors of recurrence of tuberculosis (TB), the drug resistance pattern of Mycobacterium tuberculosis strains recovered from recurrent TB patients, and the frequency of re-infection with a new M. tuberculosis strain among patients with recurrent disease. A population-based, retrospective case-control study using the Houston Tuberculosis Initiative database. We found that, among 100 patients with recurrent TB who completed adequate therapy for a first episode of TB, not receiving directly observed therapy, pulmonary disease, HIV/AIDS diagnosis, not having a family physician, being unemployed and using public transportation were predictors of recurrent disease. There was a significant increase in drug-resistant M. tuberculosis strains in the second episode of disease compared to the first episode (21.3% vs. 8.2%, P = 0.04). Exogenous re-infection with a new strain of M. tuberculosis was found to cause 24-31% of recurrent TB. Recurrent TB in Houston is associated with a significant increase in drug-resistant M. tuberculosis strains. Re-infection with a new M. tuberculosis strain causes a significant proportion of recurrent TB in an area of low TB incidence. Patients with HIV/AIDS constitute a population at increased risk of disease recurrence.
- 1 December 2003
- Vol. 7 (12) , 1178-85
Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis.
The increases in extra-pulmonary tuberculosis (EPTB) have been largely due to human immunodeficiency virus co-infection. The rates of EPTB have remained constant despite the decline in pulmonary tuberculosis (PTB) cases. To evaluate covariates associated with EPTB. A 4-year cohort of EPTB patients was compared with PTB cases. Enrollees were assessed for TB risk, medical records were reviewed, and Mycobacterium tuberculosis isolates were fingerprinted. We identified 538 EPTB cases (28.6%) in a total of 1878 enrollees. The most common sites of infection were lymph nodes (43%) and pleura (23%). EPTB cases included 320 (59%) males, 382 (71%) patients were culture-positive, and 332 (86.9%) patient isolates were fingerprinted. Fewer EPTB than PTB patients belonged to clustered M. tuberculosis strains (58% vs. 65%; P = 0.02). A multivariate model identified an increased risk for EPTB among African Americans (OR = 1.9, P = 0.01), HIV-seropositive (OR = 3.1, P < 0.01), liver cirrhosis (OR = 2.3, P = 0.02), and age <18 years (OR = 2.0, P = 0.04). Patients with concomitant pulmonary and extra-pulmonary infections were more likely to die within 6 months of TB diagnosis (OR = 2.3, P < 0.01). African American ethnicity is an independent risk factor for EPTB. Mortality at 6 months is partly due to the dissemination of M. tuberculosis and the severity of the underlying co-morbidity.
- 1 December 2003
- Vol. 7 (12) , 1178-85
Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis.
The increases in extra-pulmonary tuberculosis (EPTB) have been largely due to human immunodeficiency virus co-infection. The rates of EPTB have remained constant despite the decline in pulmonary tuberculosis (PTB) cases. To evaluate covariates associated with EPTB. A 4-year cohort of EPTB patients was compared with PTB cases. Enrollees were assessed for TB risk, medical records were reviewed, and Mycobacterium tuberculosis isolates were fingerprinted. We identified 538 EPTB cases (28.6%) in a total of 1878 enrollees. The most common sites of infection were lymph nodes (43%) and pleura (23%). EPTB cases included 320 (59%) males, 382 (71%) patients were culture-positive, and 332 (86.9%) patient isolates were fingerprinted. Fewer EPTB than PTB patients belonged to clustered M. tuberculosis strains (58% vs. 65%; P = 0.02). A multivariate model identified an increased risk for EPTB among African Americans (OR = 1.9, P = 0.01), HIV-seropositive (OR = 3.1, P < 0.01), liver cirrhosis (OR = 2.3, P = 0.02), and age <18 years (OR = 2.0, P = 0.04). Patients with concomitant pulmonary and extra-pulmonary infections were more likely to die within 6 months of TB diagnosis (OR = 2.3, P < 0.01). African American ethnicity is an independent risk factor for EPTB. Mortality at 6 months is partly due to the dissemination of M. tuberculosis and the severity of the underlying co-morbidity.
- 1 October 2003
- Vol. 7 (10) , 987-93
Extrathoracic tuberculosis lymphadenitis in adult HIV seronegative patients: a population-based analysis in Houston, Texas, USA.
To evaluate the covariates associated with extrathoracic tuberculosis lymphadenitis (ETBL) among adult HIV-seronegative patients. Enrollees were interviewed for TB risk assessment, their medical records were reviewed, and their Mycobacterium tuberculosis isolates underwent molecular characterization. Between 1 October 1995 and 30 September 1999, HIV-negative patients with ETBL were compared with other HIV-negative TB patients. We identified 73 ETBL cases (5%) out of a total of 1371 adult HIV-negative enrollees. Significant variables predicting ETBL in the univariate analysis included age < 45 years, female sex, Asian ethnicity, foreign birth, BCG vaccination, and infection with a M. tuberculosis isolate identified in major genetic group 1. Further analysis by birth country revealed increased ETBL risk for persons from countries other than the Americas and with a TB incidence > 25 per 100 000 per year. The multivariate model demonstrated increased risk for ETBL for patients of female sex (OR = 2.6, P < 0.01) and birth in Africa or South-east Asia (OR = 4.8; P = 0.03 and OR = 33.6; P = 0.01, respectively). In adult HIV-negative patients, ETBL occurs more frequently in females and in immigrants from countries other than the Americas; persons from India, South-east Asia and the Eastern Mediterranean exhibited the highest risk among these regions.
- 1 October 2003
- Vol. 7 (10) , 987-93
Extrathoracic tuberculosis lymphadenitis in adult HIV seronegative patients: a population-based analysis in Houston, Texas, USA.
To evaluate the covariates associated with extrathoracic tuberculosis lymphadenitis (ETBL) among adult HIV-seronegative patients. Enrollees were interviewed for TB risk assessment, their medical records were reviewed, and their Mycobacterium tuberculosis isolates underwent molecular characterization. Between 1 October 1995 and 30 September 1999, HIV-negative patients with ETBL were compared with other HIV-negative TB patients. We identified 73 ETBL cases (5%) out of a total of 1371 adult HIV-negative enrollees. Significant variables predicting ETBL in the univariate analysis included age < 45 years, female sex, Asian ethnicity, foreign birth, BCG vaccination, and infection with a M. tuberculosis isolate identified in major genetic group 1. Further analysis by birth country revealed increased ETBL risk for persons from countries other than the Americas and with a TB incidence > 25 per 100 000 per year. The multivariate model demonstrated increased risk for ETBL for patients of female sex (OR = 2.6, P < 0.01) and birth in Africa or South-east Asia (OR = 4.8; P = 0.03 and OR = 33.6; P = 0.01, respectively). In adult HIV-negative patients, ETBL occurs more frequently in females and in immigrants from countries other than the Americas; persons from India, South-east Asia and the Eastern Mediterranean exhibited the highest risk among these regions.
- Open Access
- 15 September 2003
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 188 (6) , 818-827
Molecular Genetic Analysis of 675 Group AStreptococcusIsolates Collected in a Carrier Study at Lackland Air Force Base, San Antonio, Texas
Contemporary molecular genetic analysis methods have not been used to study large samples of carriage isolates of group A Streptococcus. To determine
- 15 September 2003
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 188 (6) , 818-827
Open AccessMolecular Genetic Analysis of 675 Group AStreptococcusIsolates Collected in a Carrier Study at Lackland Air Force Base, San Antonio, Texas
Contemporary molecular genetic analysis methods have not been used to study large samples of carriage isolates of group A Streptococcus. To determine
- 1 September 2002
- Vol. 6 (9) , 818-23
5' dinucleotide repeat polymorphism of NRAMP1 and susceptibility to tuberculosis among Caucasian patients in Houston, Texas.
Houston Tuberculosis Initiative (HTI) and Baylor College of Medicine, Houston, Texas. To further explore the association between the polymorphisms of NRAMP1 and human susceptibility/resistance to tuberculosis (TB), specifically to determine whether the reported association shown for blacks and Asians holds true for Caucasian populations. In a case-control study, 135 adult Caucasian TB patients and 108 adult Caucasian HIV-seronegative non-TB controls were analyzed for the association between the polymorphisms in NRAMP1 gene and clinical TB. Heterozygote at 5'(GT)n, a dinucleotide repeat polymorphism in the promoter of NRAMP1, was observed at significantly higher frequencies among HIV-negative patients with pulmonary TB (41.6%; OR 2.02; 95%CI 1.11-3.64), extra-pulmonary TB (66.7%; OR 4.80; 95%CI 1.34-17.15), and HIV-seropositive TB patients (50%; OR 3.77; 95%CI 1.33-10.66) in comparison with the controls (27.8%). Homozygotes (GT)(10,10) were over-represented among HIV-positive TB patients (18.2%; OR 6.86; 95%CI 1.55-30.21) compared to the controls (5.5%). These findings suggest that the 5'(GT)n polymorphism of NRAMP1 modifies TB susceptibility in this Caucasian population, and could possibly be related to the site of infection among HIV-negative individuals and HIV-coinfected TB.
- 1 September 2002
- Vol. 6 (9) , 818-23
5' dinucleotide repeat polymorphism of NRAMP1 and susceptibility to tuberculosis among Caucasian patients in Houston, Texas.
Houston Tuberculosis Initiative (HTI) and Baylor College of Medicine, Houston, Texas. To further explore the association between the polymorphisms of NRAMP1 and human susceptibility/resistance to tuberculosis (TB), specifically to determine whether the reported association shown for blacks and Asians holds true for Caucasian populations. In a case-control study, 135 adult Caucasian TB patients and 108 adult Caucasian HIV-seronegative non-TB controls were analyzed for the association between the polymorphisms in NRAMP1 gene and clinical TB. Heterozygote at 5'(GT)n, a dinucleotide repeat polymorphism in the promoter of NRAMP1, was observed at significantly higher frequencies among HIV-negative patients with pulmonary TB (41.6%; OR 2.02; 95%CI 1.11-3.64), extra-pulmonary TB (66.7%; OR 4.80; 95%CI 1.34-17.15), and HIV-seropositive TB patients (50%; OR 3.77; 95%CI 1.33-10.66) in comparison with the controls (27.8%). Homozygotes (GT)(10,10) were over-represented among HIV-positive TB patients (18.2%; OR 6.86; 95%CI 1.55-30.21) compared to the controls (5.5%). These findings suggest that the 5'(GT)n polymorphism of NRAMP1 modifies TB susceptibility in this Caucasian population, and could possibly be related to the site of infection among HIV-negative individuals and HIV-coinfected TB.
- 1 July 2001
- Vol. 5 (7) , 633-41
The contribution of ethnicity to Mycobacterium tuberculosis strain clustering.
Descriptive study of molecular epidemiologic patterns of tuberculosis cases among ethnic minorities in Houston, Texas. Population-based, prospective, active surveillance, and molecular epidemiology study. Tuberculosis cases reported to the City of Houston Tuberculosis Control Office between October 1995 and September 1998. During the study period, 1,139 culture-positive patients were enrolled for whom isolates of their culture specimen were available. Of these, 910 were part of an ethnic minority. Molecular characterization identified 689 of 1,139 isolates to be clonally related. Factors significantly associated with tuberculosis strain clustering in a multivariable logistic regression analysis were: birth in the United States, a history of homelessness, infection with the human immunodeficiency virus (HIV), pulmonary disease, infection with a tuberculosis strain from principal genetic group 1 or 3, living in a residence with five or more persons present, and use of public transportation more than once weekly. Asian ethnicity and increasing age were associated with decreased odds of clustering. Ethnicity was not a significant covariate for strain clustering after adjustments for factors related to socio-economic status.
- 1 July 2001
- Vol. 5 (7) , 633-41
The contribution of ethnicity to Mycobacterium tuberculosis strain clustering.
Descriptive study of molecular epidemiologic patterns of tuberculosis cases among ethnic minorities in Houston, Texas. Population-based, prospective, active surveillance, and molecular epidemiology study. Tuberculosis cases reported to the City of Houston Tuberculosis Control Office between October 1995 and September 1998. During the study period, 1,139 culture-positive patients were enrolled for whom isolates of their culture specimen were available. Of these, 910 were part of an ethnic minority. Molecular characterization identified 689 of 1,139 isolates to be clonally related. Factors significantly associated with tuberculosis strain clustering in a multivariable logistic regression analysis were: birth in the United States, a history of homelessness, infection with the human immunodeficiency virus (HIV), pulmonary disease, infection with a tuberculosis strain from principal genetic group 1 or 3, living in a residence with five or more persons present, and use of public transportation more than once weekly. Asian ethnicity and increasing age were associated with decreased odds of clustering. Ethnicity was not a significant covariate for strain clustering after adjustments for factors related to socio-economic status.
- Open Access
- 1 February 2000
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (2) , 535-542
Nonpolar Inactivation of the Hypervariable Streptococcal Inhibitor of Complement Gene ( sic ) in Serotype M1 Streptococcus pyogenes Significantly Decreases Mouse Mucosal Colonization
Group A Streptococcus (GAS) is a human pathogen that commonly infects the upper respiratory tract. GAS serotype M1 strains are frequently isolated from human infections and contain the gene encoding the hypervariable streptococcal inhibitor of complement protein (Sic). It was recently shown that Sic variants were rapidly selected on mucosal surfaces in epidemic waves caused by M1 strains, an observation suggesting that Sic participates in host-pathogen interactions on the mucosal surface (N. P. Hoe, K. Nakashima, S. Lukomski, D. Grigsby, M. Liu, P. Kordari, S.-J. Dou, X. Pan, J. Vuopio-Varkila, S. Salmelinna, A. McGeer, D. E. Low, B. Schwartz, A. Schuchat, S. Naidich, D. De Lorenzo, Y.-X. Fu, and J. M. Musser, Nat. Med. 5:924–929, 1999). To test this idea, a new nonpolar mutagenesis method employing a spectinomycin resistance cassette was used to inactivate the sic gene in an M1 GAS strain. The isogenic Sic-negative mutant strain was significantly ( P < 0.019) impaired in ability to colonize the mouse mucosal surface after intranasal infection. These results support the hypothesis that the predominance of M1 strains in human infections is related, in part, to a Sic-mediated enhanced colonization ability.
- 1 February 2000
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (2) , 535-542
Open AccessNonpolar Inactivation of the Hypervariable Streptococcal Inhibitor of Complement Gene ( sic ) in Serotype M1 Streptococcus pyogenes Significantly Decreases Mouse Mucosal Colonization
Group A Streptococcus (GAS) is a human pathogen that commonly infects the upper respiratory tract. GAS serotype M1 strains are frequently isolated from human infections and contain the gene encoding the hypervariable streptococcal inhibitor of complement protein (Sic). It was recently shown that Sic variants were rapidly selected on mucosal surfaces in epidemic waves caused by M1 strains, an observation suggesting that Sic participates in host-pathogen interactions on the mucosal surface (N. P. Hoe, K. Nakashima, S. Lukomski, D. Grigsby, M. Liu, P. Kordari, S.-J. Dou, X. Pan, J. Vuopio-Varkila, S. Salmelinna, A. McGeer, D. E. Low, B. Schwartz, A. Schuchat, S. Naidich, D. De Lorenzo, Y.-X. Fu, and J. M. Musser, Nat. Med. 5:924–929, 1999). To test this idea, a new nonpolar mutagenesis method employing a spectinomycin resistance cassette was used to inactivate the sic gene in an M1 GAS strain. The isogenic Sic-negative mutant strain was significantly ( P < 0.019) impaired in ability to colonize the mouse mucosal surface after intranasal infection. These results support the hypothesis that the predominance of M1 strains in human infections is related, in part, to a Sic-mediated enhanced colonization ability.
- Open Access
- 1 November 1999
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 180 (5) , 1751-1752
Mutations in Genes Associated with Drug Resistance inMycobacterium tuberculosisIsolates from Italy
Cingolani et al. [1] recently described the results of an analysis of gene mutations associated with drug resistance in isolates of Mycobacterium tuberculosis recovered from patients in a reference hospital in Italy. The authors used nucleotide sequence analysis and other molecular methods to identify mutations in 7 genes previously reported to contain mutations associated with resistance to rifampin (rpoB), isoniazid (katG, inhA, and ahpC), streptomycin (rpsL and rrs), and ethambutol (embB; reviewed in [2]). Although the authors extend understanding of the molecular genetics of drug resistance to isolates from Italy, some of the data warrant additional explanation because they differ substantially from extensive analyses conducted in many areas. With regard to katG polymorphisms associated with isoniazid resistance, all published results, including our study of several thousand M. tuberculosis complex isolates from worldwide sources [2, 3], as well as our unpublished data, have shown that amino acid 463 in susceptible organisms is either an arginine or a leucine residue. In contrast, Cingolani et al. report in table 2 of their article that one isolate (T60) had an alanine residue at residue 463 in the wild-type condition that was replaced with a histidine in the isoniazid-resistant mutant organism. The authors' basis for reporting that an isoniazid-susceptible isolate of M. tuberculosis had alanine at position 463 is unclear. They also report that two resistant organisms (T4 and T50) had an Arg463His amino acid replacement and one organism (T10) had an Arg463→stop mutation. (Note that two isolates are designated “T50” in their published table 2; we refer to the second T50 isolate.) Inasmuch as these changes have not been previously identified [2], it is important to report the actual nucleotide changes found. The authors report a Gln294His amino acid replacement in a resistant isolate (isolate T30; table 2 of their publication), but residue 294 in M. tuberculosis complex organisms is glutamic acid, not glutamine. We also presume that their suggestion in the Discussion to perform mutational analysis of region 135 of katG should actually refer to the codon 315 region.
- 1 November 1999
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 180 (5) , 1751-1752
Open AccessMutations in Genes Associated with Drug Resistance inMycobacterium tuberculosisIsolates from Italy
Cingolani et al. [1] recently described the results of an analysis of gene mutations associated with drug resistance in isolates of Mycobacterium tuberculosis recovered from patients in a reference hospital in Italy. The authors used nucleotide sequence analysis and other molecular methods to identify mutations in 7 genes previously reported to contain mutations associated with resistance to rifampin (rpoB), isoniazid (katG, inhA, and ahpC), streptomycin (rpsL and rrs), and ethambutol (embB; reviewed in [2]). Although the authors extend understanding of the molecular genetics of drug resistance to isolates from Italy, some of the data warrant additional explanation because they differ substantially from extensive analyses conducted in many areas. With regard to katG polymorphisms associated with isoniazid resistance, all published results, including our study of several thousand M. tuberculosis complex isolates from worldwide sources [2, 3], as well as our unpublished data, have shown that amino acid 463 in susceptible organisms is either an arginine or a leucine residue. In contrast, Cingolani et al. report in table 2 of their article that one isolate (T60) had an alanine residue at residue 463 in the wild-type condition that was replaced with a histidine in the isoniazid-resistant mutant organism. The authors' basis for reporting that an isoniazid-susceptible isolate of M. tuberculosis had alanine at position 463 is unclear. They also report that two resistant organisms (T4 and T50) had an Arg463His amino acid replacement and one organism (T10) had an Arg463→stop mutation. (Note that two isolates are designated “T50” in their published table 2; we refer to the second T50 isolate.) Inasmuch as these changes have not been previously identified [2], it is important to report the actual nucleotide changes found. The authors report a Gln294His amino acid replacement in a resistant isolate (isolate T30; table 2 of their publication), but residue 294 in M. tuberculosis complex organisms is glutamic acid, not glutamine. We also presume that their suggestion in the Discussion to perform mutational analysis of region 135 of katG should actually refer to the codon 315 region.
- Open Access
- 1 October 1999
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 180 (4) , 1245-1251
Complex Transmission Dynamics of Clonally Related VirulentMycobacterium tuberculosisAssociated with Barhopping by Predominantly Human Immunodeficiency Virus–Positive Gay Men
Limited data suggest that measures to reduce tuberculosis transmission should be based on locations rather than on personal contacts. Molecular epide
- 1 October 1999
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 180 (4) , 1245-1251
Open AccessComplex Transmission Dynamics of Clonally Related VirulentMycobacterium tuberculosisAssociated with Barhopping by Predominantly Human Immunodeficiency Virus–Positive Gay Men
Limited data suggest that measures to reduce tuberculosis transmission should be based on locations rather than on personal contacts. Molecular epide
- 1 April 1999
- Vol. 67 (4) , 1779-88
Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice.
The role of an extracellular cysteine protease encoded by the speB gene in group A Streptococcus (GAS) skin infection was studied with a mouse model. Mice were injected subcutaneously with a wild-type GAS serotype M3 strain or a cysteine protease-inactivated isogenic derivative grown to stationary phase. The mortality rate of mice injected with the M3 speB mutant strain was significantly decreased (P < 0.0008) compared to that of animals injected with the wild-type parental organism. The abscesses formed in animals infected with the cysteine protease mutant strain were significantly smaller (P < 0.0001) than those caused by the wild-type organism and slowly regressed over 3 to 4 weeks. In striking contrast, infection with the wild-type GAS isolate generated necrotic lesions, and in some animals the GAS disseminated widely from the injection site and produced extensive cutaneous damage. All of these animals developed bacteremia and died. GAS dissemination was accompanied by severe tissue and blood vessel necrosis. Cysteine protease expression in the infected tissue was identified by immunogold electron microscopy. These data demonstrate that cysteine protease expression contributes to soft tissue pathology, including necrosis, and is required for efficient systemic dissemination of the organism from the initial site of skin inoculation.
- 1 April 1999
- Vol. 67 (4) , 1779-88
Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice.
The role of an extracellular cysteine protease encoded by the speB gene in group A Streptococcus (GAS) skin infection was studied with a mouse model. Mice were injected subcutaneously with a wild-type GAS serotype M3 strain or a cysteine protease-inactivated isogenic derivative grown to stationary phase. The mortality rate of mice injected with the M3 speB mutant strain was significantly decreased (P < 0.0008) compared to that of animals injected with the wild-type parental organism. The abscesses formed in animals infected with the cysteine protease mutant strain were significantly smaller (P < 0.0001) than those caused by the wild-type organism and slowly regressed over 3 to 4 weeks. In striking contrast, infection with the wild-type GAS isolate generated necrotic lesions, and in some animals the GAS disseminated widely from the injection site and produced extensive cutaneous damage. All of these animals developed bacteremia and died. GAS dissemination was accompanied by severe tissue and blood vessel necrosis. Cysteine protease expression in the infected tissue was identified by immunogold electron microscopy. These data demonstrate that cysteine protease expression contributes to soft tissue pathology, including necrosis, and is required for efficient systemic dissemination of the organism from the initial site of skin inoculation.